Danoprevir (INN) is an orally available 15-membered macrocyclic peptidomimetic inhibitor of NS3/4A HCV protease. It contains acylsulfonamide, fluoroisoindole...
7 KB (487 words) - 04:54, 20 October 2023
NS3/4A protease inhibitors (–previr) Asunaprevir Boceprevir‡ Ciluprevir§ Danoprevir† Faldaprevir‡ Glecaprevir Grazoprevir Narlaprevir Paritaprevir Simeprevir...
26 KB (2,541 words) - 05:04, 4 January 2024
combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised...
6 KB (901 words) - 10:55, 29 March 2024
(INN) daniquidone (INN) danitracen (INN) Danocrine danofloxacin (INN) danoprevir (INN) danosteine (INN) Dantrium dantrolene (INN) dantron (INN) dapabutan...
6 KB (323 words) - 04:59, 24 February 2024
to design new macrocyclic inhibitors such as simeprevir (TMC-435) and danoprevir. Tan SL, He Y, eds. (2011). Hepatitis C: Antiviral Drug Discovery and...
4 KB (221 words) - 23:58, 3 April 2023
combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised...
4 KB (289 words) - 02:12, 29 March 2024